
First-ever use of donor gum cells to treat osteoarthritis
Scarcell Therapeutics has treated the first patients with its allogenic gingival fibroblast (aGF) therapy using gum cells from a human donor as part of its Phase Ib clinical trial studying the therapy in knee osteoarthritis (OA). The first-in-human cases took place at Oxford University Hospitals, UK, and… Read More














